JANX Janux Therapeutics, Inc.: institutional ownership and insider trading
213 funds reported holding $1.05B of Janux Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $74.1M, with 37 new positions and 31 funds selling out; over the last 12 months insiders bought $0 and sold $1.06M on the open market; over its last four quarters it reported revenue of $24.0M and net income of −$103M.
JANX revenue and earnings
- Quarter ended Jun 30, 2026: revenue $10.3M, net income −$22.0M, EPS -0.35
- Quarter ended Mar 31, 2026: revenue $3.73M, net income −$24.4M, EPS -0.39
- Quarter ended Dec 31, 2025: revenue $0, net income −$31.9M, EPS -0.51
- Quarter ended Sep 30, 2025: revenue $10.0M, net income −$24.3M, EPS -0.39
Famous investors holding JANX
- Two Sigma (Two Sigma Investments): $18.5M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $16.8M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $19.4M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $7.75M, 0.0% of the portfolio
Largest institutional holders of JANX
- RA CAPITAL MANAGEMENT, L.P. — $172M
- BlackRock, Inc. (BLK) — $94.2M
- Prosight Management, LP — $58.4M
- JANUS HENDERSON GROUP PLC (JHG) — $58.3M
- STATE STREET CORP (STT, STT-PG) — $46.2M
- VANGUARD GROUP INC — $40.1M
- FMR LLC — $37.1M
- FEDERATED HERMES, INC. (FHI) — $36.1M
- Point72 Asset Management, L.P. — $30.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $28.5M
Recent JANX insider trades
- Jun 2, 2026: Doyle Janeen Noel sold 4,059 shares ($56.9K)
- May 11, 2026: Dobek Maria sold 2,038 shares ($28.9K)
- Jan 2, 2026: Campbell David Alan sold 8,072 shares ($111K)
- Jan 2, 2026: Meyer Andrew Hollman sold 1,879 shares ($25.8K)
5%+ owners
- JANUS HENDERSON GROUP PLC: 6.9% (Schedule 13G/A, filed May 15, 2026)
- BlackRock, Inc.: 6.7% (Schedule 13G/A, filed Jul 28, 2026)
Who owns the most JANX stock?
The largest institutional holders of Janux Therapeutics, Inc. in the latest 13F filings are RA CAPITAL MANAGEMENT, L.P. ($172M), BlackRock, Inc. (BLK) ($94.2M), Prosight Management, LP ($58.4M).
Are insiders buying or selling JANX?
Over the last 12 months insiders bought $0 and sold $1.06M of Janux Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own JANX?
Two Sigma, D. E. Shaw, Ken Griffin, Izzy Englander.
What was JANX's revenue last quarter?
Janux Therapeutics, Inc. reported revenue of $10.3M for the quarter ended June 30, 2026, with net income of −$22.0M.
Which ETFs hold JANX?
10 ETFs and mutual funds hold it among their top 100 positions, including QASCX, QASGX, FBTAX, IDNA.